Parkinsons Disease Flashcards

1
Q

CLINICAL MANIFESTATIONS

OF

EMOTIONAL CHANGES

(3)

A
  1. DEPRESSION
  2. FEAR, ANXIETY, PANIC ATTACK
  3. INABILITY TO COPE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

“3” things affected by Parkinson’s Disease

A

1) Voluntary Movement 2) Cognitive Changes 3) Emotional changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

“4” classic motor symptoms associated

with Parkinson’s Disease

A

“TRAP”

Tremors

Rigidity

Akinesia

Postural Instability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Clients with Bradykinesia, tremors & rigidity that DO NOT RESPOND to Dopaminergic drugs are typically said to have ____________________

A

PARKINSONISM instead of Parkinsons Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

CLINICAL MANIFESTATIONS

associated with TREMORS

(5)

A
  1. Early sign–typicallys begins with 1 hand, foot, etc.
  2. more prominent when pt is at rest (declines with movement)
  3. “PILL ROLLING”
  4. Exacerbated by Stress /Anxiety
  5. Progressive Difficulty with ADL’s
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

bradykinesia

A

slow movements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

DIAGNOSTIC TESTING

for

PARKINSON DISEASE

(6)

A
  • Presenting symptoms
  • neurological exam
  • response to medication (favorable outcome to levodopa / carbidopa)
  • DaT Scan
  • MRI
    • Client w/PD will have normal exam from MRI and/or CT scan
    • This will rule out other causes
  • 2 of 4 TRAP CRITERIA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

DaT Scan

A

**identifies lack of dopamine receptors in the brain

  1. Binds to dopamine transporters
  2. *clients w/degeneration of dopamine will show less uptake**thyroid needsblocked before injection of radioactive dye to prevent thyroid accumulation*

IT CAN: DIFFERENTIATE BETWEEN ESSENTIAL TREMORS & TREMORS R/T PARKINSONIAN SYNDROME.

IT CAN NOT:differentiate between parkinson disease and other dopamine degenerative disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

“5” stages of Parkinson’s Disease

A

STAGE 1: Shaking/tremor in 1 extremity STAGE 2: Bilateral extremities affected Walking/Balance Poor STAGE 3: Slowed Physical Movement Walking more affected STAGE 4: Akinesia & rigidity make ADL’s difficult STAGE 5: Unable to stand/Walk Dependent for all care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is

DEEP BRAIN STIMULATION?

A

**Electrode implanted in Thalmus

-Current delivered by small pulse generator implanted under the skin of upper chest

  • Decreases Tremors
  • Reduces rigidity
  • Improved Akinesia
  • Allows for decreased dose of Levodopa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Define Dysarthria

A

Slurred or Slowed speech

Difficult to understand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

NON-MOTOR SYMPTOMS

(7))

A
  1. FATIGUE
  2. LOSS OF SMELL
  3. DEMEN TIA\
  4. DEPRESSION
  5. SLEEP DISORDERS
  6. CONSTIPATION
  7. URINARYFREQUEMCY / RETENTION
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

WHAT IS PARKINSONISM?

Causes???

(3)

A
  • **individuals w/the combination of motor symptoms typically seen in Pakinson Disease.*
  • <strong>**not everyone that has parkinsonism has PD.</strong>*

CAUSES:

  • MEDICATIONS
  • HEAD TRAUMA
  • NEURODEGENERATIVE DISORDERS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

RISK FACTORS (2)

A

1) AGE (Primary Risk Factor)—average age onset between 40-70 2) GENDER —Males at increased risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Typically, Dopamine must be decreased by __________ before the patient begins to exhibit signs and/or symptoms

A

70%

17
Q

CLINICAL MANIFESTATIONS

OF

SLEEP PROBLEMS

(4)

A
  1. daytime sleep attacks
  2. restless leg syndrome
  3. insomnia
  4. parasomnia
18
Q

DEFINE

“BRADYKINESIA”

A

ABNORMALLY SLOW MOVEMENTS

19
Q

This medication is converted directly to dopamine in the brain

A

LEVODOPA

20
Q

The medications used to treat Parkinson’s Disease do 1 of 2 things

A
  1. prevent breakdown of dopamine
  2. replicate action of dopamine
21
Q

When given orally, medication such as LEVODOPA are converted to ______ in the brainn, increasing dopamine levels in the _______ _________.

A

DOPAMINE

BASAL GANGLIA

22
Q

Levodopa is a ______________

(class of medication)

A

DOPAMINERGIC

23
Q

Dopamingerics may be combined with ________________ to descrease peripheral metabolism of Levodopa.

A

Carbidopa

24
Q

“2” Nursing considerations for Dopaminergic medications

A
  1. monitor for “weaning off” phenomenon
  2. Dyskinesias…….(which can indicate the need to adjust the dosage or time of administration)
25
Q

Dopamine

A

brain neurotransmitter that is needed for voluntary movement

26
Q
A
27
Q

Potential Nursing Diagnoses

for Parkinsons Disease

(7)

A
  • Risk for Falls
  • Impaired Physical Mobility
  • Impaired verbal communication
  • Risk for Aspiration
  • Self-Care Deficit
  • Impaired urinary elimination
  • Constipation
28
Q

Define “RIGIDITY”

A

Resistance to Movement

29
Q

CLINICAL MANIFESTATIONS

AKINESIA

VOLUNTARY (1) AUTOMATIC MOVEMENTS (4)

A

VOLUNTARY

1) progressive difficulty w/ADL’s

AUTOMATIC MOVEMENTS

  • 1) Excessive Drooling*
  • 2) Difficulty Chewing / swallowing*
  • 3) Slow / slurred speech <strong>(dysarthria)</strong>*
  • 4) Hypophonia (<strong>low volume)</strong>*
30
Q

CLINICAL MANIFESTATIONS

OF

RIGIDITY

(3)

A
  1. MUSCLE CONTRACTION
  2. LIMITED ROM
  3. “COGWHEEL RIGIDITY”
31
Q

This medications’ “therapeutic” effectiveness diminishes with increasing doses and long term exposure

A

Levodopa (Dopaminergic)

32
Q

DEFINE

“AKINESIA”

A

ABSENCE OF MOVEMENT

33
Q

Clinical Manifestations

of

COGNITIVE PROBLEMS

(4)

A
  1. SLOWED THINKING
  2. MEMORY LOSS
  3. DEMENTIA (*later in disease progression)
  4. CONFUSION
34
Q

Dopaminergics may be combined with ___________ to decrease peripheral metabolism leading to less medication needed to gain a therapeautic effect

A

Carbidopa

35
Q

Carbidopa and

Levidopa together are known

as ____________ (Name of drug)

A

Sinemet

36
Q

CAUSES of Parkinson’s Disease (3)

A

1) Idiopathic mostly 2) Genetic Predisposition 3) Exposure to environmental toxins/chemicals

37
Q

CLINICAL MANIFESTATIONS

OF

POSTURAL INSTABILITY

(4)

A
  1. Stooped Posture
  2. Retropulsion (tendancy to topple backward)
  3. Parkinson Gait (shuffling gait-small steps) with FESTINATION = involuntary quickening of gait
  4. Freezing of Gait—pt feels like they are stuck to the floor—–>increased risk of falling